Rahul Khara is Chief Legal Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 14,035 shares of GMTX, which is worth approximately $342,032. The most recent transaction as insider was on Jan 02, 2025, when has been sold 7,500 shares (Common Stock) at a price of $63.01 per share, resulting in proceeds of $472,575. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K
0% 3M change
0% 12M change
Total Value Held $342,032

Rahul Khara Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Open market or private sale
$472,575 $63.01 p/Share
7,500 Reduced 34.83%
14,035 Common Stock
Jan 02 2025
BUY
Exercise of conversion of derivative security
$110,175 $14.69 p/Share
7,500 Added 25.83%
21,535 Common Stock
Jan 10 2024
BUY
Grant, award, or other acquisition
-
14,035 Added 50.0%
14,035 Common Stock
Nov 22 2023
SELL
Open market or private sale
$510,500 $51.05 p/Share
10,000 Reduced 100.0%
0 Common Stock
Nov 22 2023
BUY
Exercise of conversion of derivative security
$146,900 $14.69 p/Share
10,000 Added 50.0%
10,000 Common Stock
Nov 14 2023
SELL
Open market or private sale
$248,871 $50.79 p/Share
4,900 Reduced 100.0%
0 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$71,981 $14.69 p/Share
4,900 Added 50.0%
4,900 Common Stock
Nov 03 2023
SELL
Open market or private sale
$5,000 $50.0 p/Share
100 Reduced 100.0%
0 Common Stock
Nov 03 2023
BUY
Exercise of conversion of derivative security
$1,469 $14.69 p/Share
100 Added 50.0%
100 Common Stock
RK

Rahul Khara

Chief Legal Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Track Activities on GMTX